Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06055803 · ClinicalTrials.gov registry record · NA

Heart Health After Cancer Treatment (HEART-ACT)

A NA study of Breast Cancer, sponsored by University of California, San Francisco.

Active
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT06055803 is a NA study of Breast Cancer that is active but no longer recruiting, run by University of California, San Francisco. The registered enrollment target is 50 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06055803, a NA study of Breast Cancer, is active but no longer recruiting, sponsored by University of California, San Francisco.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

This is a pilot study testing multi-disciplinary health behavior intervention in breast cancer survivors who have been treated at Zuckerberg San Francisco General (ZSFG).

Conditions Studied

Interventions

  • BEHAVIORAL Exercise
  • BEHAVIORAL Intake Session
  • BEHAVIORAL Individual Sessions
  • BEHAVIORAL Group Sessions
  • BEHAVIORAL Graduation

Study Locations (1)

California

  • Zuckerberg San Francisco General - San Francisco

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2023-11-07
Est. Completion 2026-06-30
Phase NA

What the Registry Record Tells You About NCT06055803

The ClinicalTrials.gov registry entry for NCT06055803 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (98% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 5 interventions - of which Exercise is the first listed.

NCT06055803 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06055803 about?

NCT06055803 is a clinical study titled "Heart Health After Cancer Treatment (HEART-ACT)". This is a pilot study testing multi-disciplinary health behavior intervention in breast cancer survivors who have been treated at Zuckerberg San Francisco General (ZSFG).

What is the current status of trial NCT06055803?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2023-11-07. Estimated completion is 2026-06-30.

What conditions does trial NCT06055803 study?

This clinical trial studies the following conditions: Breast Cancer.

What interventions are being tested in trial NCT06055803?

The interventions under investigation include: Exercise (BEHAVIORAL), Intake Session (BEHAVIORAL), Individual Sessions (BEHAVIORAL), Group Sessions (BEHAVIORAL), Graduation (BEHAVIORAL).

Who is sponsoring clinical trial NCT06055803?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06055803 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.